Terry’s nails are seen in:
**Core Concept**
Terry's nails are a clinical manifestation associated with a specific systemic condition, characterized by a unique appearance of the fingernails. This condition is often linked to underlying pathophysiological changes in the nail bed.
**Why the Correct Answer is Right**
Terry's nails are typically seen in patients with systemic lupus erythematosus (SLE), a chronic autoimmune disorder. The characteristic appearance of Terry's nails is due to the inflammation and scarring of the nail matrix, leading to a distinctive pattern of nail discoloration and thinning. This is often accompanied by the presence of nail bed capillaries, which are a hallmark of SLE.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Beau's lines are a different nail change that can be seen in various systemic conditions, including but not limited to hypocalcemia, systemic infections, and medication-induced nail changes. Beau's lines are horizontal ridges on the nail plate, resulting from changes in nail growth.
**Option B:** This option is incorrect because Muehrcke's nails are a different type of nail change characterized by horizontal white bands on the nail plate, often seen in patients with hypoproteinemia, chronic kidney disease, or other systemic conditions. Muehrcke's nails are distinct from Terry's nails in both appearance and underlying cause.
**Option C:** This option is incorrect because Half-and-half nails are a different type of nail change characterized by a mixture of white and pink coloration on the nail plate, often seen in patients with psoriasis or other autoimmune conditions. Half-and-half nails are distinct from Terry's nails in both appearance and underlying cause.
**Clinical Pearl / High-Yield Fact**
Terry's nails are often seen in patients with SLE, but they can also be seen in other autoimmune conditions, such as scleroderma and rheumatoid arthritis. Remember that nail changes can be a valuable clue to underlying systemic disease.
**Correct Answer: B. Systemic lupus erythematosus (SLE)**